Raymond James Financial Services Advisors, Inc. Matinas Bio Pharma Holdings, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$0.15 - $0.37 $1,650 - $4,070	11,000 New	11,000 $1,000
Q4 2020 Feb 12, 2021	SELL	$0.76 - $1.47 $543,358 - $1.05 Million	-714,946 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$0.67 - $0.96 $8,710 - $12,480	13,000 Added 1.85%	714,946 $548,000
Q2 2020 Jul 17, 2020	SELL	$0.52 - $0.92 $52,000 - $92,000	-100,000 Reduced 12.47%	701,946 $543,000
Q1 2020 Apr 21, 2020	BUY	$0.6 - $2.31 $4,320 - $16,632	7,200 Added 0.91%	801,946 $481,000
Q4 2019 Feb 12, 2020	BUY	$0.63 - $2.27 $32,130 - $115,770	51,000 Added 6.86%	794,746 $1.8 Million
Q3 2019 Nov 07, 2019	SELL	$0.59 - $0.9 $15,295 - $23,331	-25,924 Reduced 3.37%	743,746 $469,000
Q2 2019 Aug 06, 2019	SELL	$0.79 - $1.11 $2,547 - $3,579	-3,225 Reduced 0.42%	769,670 $659,000
Q1 2019 May 06, 2019	SELL	$0.6 - $1.41 $28,800 - $67,680	-48,000 Reduced 5.85%	772,895 $842,000
Q4 2018 Feb 11, 2019	SELL	$0.53 - $1.11 $120,414 - $252,188	-227,197 Reduced 21.68%	820,895 $488,000
Q3 2018 Nov 14, 2018	BUY	$0.35 - $0.92 $94,350 - $248,006	269,572 Added 34.63%	1,048,092 $964,000
Q2 2018 Jul 30, 2018	BUY	$0.42 - $0.74 $47,628 - $83,916	113,400 Added 17.05%	778,520 $338,000
Q1 2018 Apr 16, 2018	BUY	$0.76 - $1.32 $3,974 - $6,903	5,230 Added 0.79%	665,120 $509,000
Q4 2017 Feb 09, 2018	SELL	$1.1 - $1.54 $9,350 - $13,090	-8,500 Reduced 1.27%	659,890 $765,000
Q3 2017 Oct 26, 2017	BUY	$1.19 - $1.43 $25,018 - $30,064	21,024 Added 3.25%	668,390 $882,000
Q2 2017 Aug 15, 2017	BUY	N/A	647,366	647,366 $1.09 Million

Others Institutions Holding MTNB

# of Institutions

Shares Held

3.52M

Call Options Held

Put Options Held

View Full List

About Matinas BioPharma Holdings, Inc.

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

More about MTNB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account